4th China Bio-Pharma Partnering Forum 2021 Summary

On June 25th and 26th,2021, the 4th China Bio-Pharma Partnering Forum 2021 was successfully held in Suzhou, China, by MSQ Ventures and Healife Group. We are thankful Dr. Martin Welschof for joining the panel “Subverting the traditional treatment concept and breaking the situation of tumor immunotherapy”, also Jonathan Wang, Dr. Hua Mu and Konstantin Poukalov for joining the panel “Unlocking global collaboration to accelerate innovation drug development”. What’s more, we appreciate all the company presenters and attendees who have participated in this event with us.

Presenting guests are
Juho Jalkanen MD, PhD, Chief Development Officer, Faron
Harry Shin, Chief Business Officer, Aston Sci
Jun-Young Lee, CEO, Selecxine
Tom Frohlich, Chief Business Officer, Chinook Therapeutics, Inc.
Gerard Soula, President & CEO, ADOCIA
Casi DeYoung, Chief Business Officer, Shattuck Labs
Martin Vodak, BD Manager, SOTIO

Panel Discussion: “Unlocking global collaboration to accelerate innovation drug development”

if you are interested in learning more details, you are very welcomed to watch the conference video recording at Medmeeting.com.

The summit and the panel were well-received and we got highly positive feedback. MSQ Ventures will continue to boost cross-border collaboration and communication in the biopharmaceutical industry. We hope to see you again at our next event soon!